Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

Pain on the brain

March 8, 2021

NervGen receives FDA feedback on phase I plans with NVG-291

March 5, 2021

Yangtze River Pharmaceutical, Shanghai Haiyan Pharmaceutical Technology describe mu-opioid agonists

March 5, 2021

Copper chelator TDMQ-20 reverses impairments in Alzheimer's disease models

March 5, 2021

Alkermes presents new mu-opioid receptor agonists

March 4, 2021

PIPE-307 enters phase I development as potential treatment of multiple sclerosis

March 4, 2021

NeuroSense reports phase IIa data with PrimeC in ALS

March 3, 2021

FDA approves Azstarys for ADHD

March 3, 2021

New protein kinase inhibitors identified at BCI Pharma

March 3, 2021

Domain Therapeutics discovers NPFF1 antagonists

March 3, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 20, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 19, 2026
WHO declares Ebola outbreak a public health emergency of international concern
BioWorld
The threat posed by the Ebola outbreak in the Democratic Republic of Congo has intensified, with the confirmation that it is caused by the Bundibugyo species of...
Nxera Pharma prepares and tests new GPR17 antagonists
BioWorld Science
Nxera Pharma UK Ltd. has identified new uracil nucleotide/cysteinyl leukotriene receptor (GPR17; P2Y-Like) antagonists potentially useful for the treatment of...
‘Detargeted’ targeted gene therapy improves activity in Pompe
BioWorld
A new strategy aims to improve gene therapy for Pompe disease by optimizing both the genetic component that restores the function of a deficient lysosomal enzyme...